Hong Kong HIV Infections Decline for 10th Year, Late Diagnosis Remains Concern

Hong Kong Reports Decade-Long Decline in New HIV Infections

Hong Kong health officials reported 331 new HIV infections in 2025, marking the tenth consecutive year of decline since a peak of over 700 cases in 2015. This represents a greater than 50% reduction, attributed to increased awareness, preventative measures, and improved access to antiretroviral therapy. The Centre for Health Protection (CHP) emphasizes the ongoing need for early testing and treatment.

This sustained decrease in new HIV diagnoses in Hong Kong is a significant public health achievement, but it’s crucial to understand the nuances behind the numbers. While the overall trend is positive, the continued prevalence of “late presenters” – individuals diagnosed with HIV after significant immune system damage has already occurred – remains a serious concern. These late diagnoses not only compromise individual health but also increase the risk of onward transmission. Understanding the factors driving this trend, and addressing them proactively, is paramount to sustaining Hong Kong’s progress towards controlling the HIV epidemic.

In Plain English: The Clinical Takeaway

• Early Detection is Key: Finding out if you have HIV early, even if you feel healthy, allows you to start treatment sooner and protect your health.
• HIV is Manageable: With modern medications, HIV is now a chronic condition that can be effectively controlled, allowing people to live long and healthy lives.
• Prevention Works: Using condoms, getting tested regularly, and considering PrEP (pre-exposure prophylaxis) are all effective ways to reduce your risk of HIV infection.

The Challenge of Late Diagnosis and CD4 Cell Count

The CHP’s data highlights that approximately 50% of newly diagnosed individuals in Hong Kong present as “late presenters.” This means they have a significantly low CD4 cell count – a type of white blood cell crucial for immune function – or have already progressed to AIDS at the time of diagnosis. CD4 cells are the primary target of HIV; as the virus replicates, it destroys these cells, weakening the immune system. A normal CD4 count ranges from 500 to 1,600 cells per cubic millimeter of blood. Individuals with a CD4 count below 200 cells/mm³ are considered to have AIDS, making them highly vulnerable to opportunistic infections. The risk of death for late presenters is ten times higher than for those diagnosed and treated earlier in the course of infection. This underscores the critical importance of widespread testing and awareness campaigns, particularly among populations less likely to seek regular medical care.

Expanding Access to Testing and Support: New Community Initiatives

Recognizing the need to address late diagnosis, the CHP is launching two new initiatives in April: the Priority Populations Testing and Counselling Programme and the People Living with HIV (PLHIV) Support Services Programme. These programs, funded through the Partnership Programme for Community Engagement, will provide free HIV and syphilis antibody testing, psychological support, and health education to targeted groups. This strategic approach acknowledges that different populations require tailored interventions. Syphilis co-infection is a significant concern, as it can increase the risk of HIV transmission and progression. The programs aim to expand testing services, promote early prevention, and strengthen support for individuals living with HIV and their families.

Global Context and the Impact of Funding Cuts

Hong Kong’s success in reducing new HIV infections stands in contrast to the setbacks experienced in other parts of the world, particularly in regions affected by funding cuts to HIV prevention programs. As highlighted in a recent China Daily Asia article, cuts initiated during the Trump administration have severely impacted UNAIDS’ ability to implement effective prevention strategies globally. These cuts have led to shortages of essential commodities like condoms and pre-exposure prophylaxis (PrEP), as well as disruptions in testing and treatment services. PrEP, a daily pill containing antiretroviral drugs, has been shown to be highly effective in preventing HIV infection in high-risk individuals. A 2014 study published in the New England Journal of Medicine demonstrated a 99% reduction in HIV incidence among men who have sex with men taking PrEP. (NEJM, 2014). The availability and affordability of PrEP remain significant barriers to prevention in many countries.

Antiretroviral Therapy: A 30-Year Legacy of Transformation

2026 marks the 30th anniversary of the introduction of highly effective antiretroviral therapy (ART) for HIV treatment. ART doesn’t cure HIV, but it suppresses the virus to undetectable levels, preventing disease progression and significantly reducing the risk of transmission. The first ART regimens, introduced in the mid-1990s, were complex and associated with significant side effects. However, advancements in drug development have led to the creation of single-tablet regimens that are easier to take and have fewer adverse effects. The mechanism of action of ART involves targeting different stages of the HIV life cycle, including viral entry, reverse transcription, integration, and protease activity. Different classes of drugs – such as nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), and integrase inhibitors (INSTIs) – work in different ways to block viral replication.

“The success of ART is one of the most remarkable achievements in modern medicine. It has transformed HIV from a death sentence into a manageable chronic condition, allowing millions of people to live long and healthy lives.”

– Dr. Anthony Fauci, former Director of the National Institute of Allergy and Infectious Diseases (NIAID).

Hong Kong’s HIV Epidemiology: A Closer Look

The CHP data reveals a clear pattern in HIV transmission routes. In 2025, 279 of the 331 new cases were attributed to sexual contact, with 158 cases involving men who have sex with men and 121 involving heterosexual contact. This highlights the importance of targeted prevention efforts aimed at these populations. The remaining cases were attributed to other routes of transmission, such as intravenous drug apply and mother-to-child transmission. Hong Kong has implemented comprehensive measures to prevent mother-to-child transmission, including routine HIV screening for pregnant women and the provision of ART to HIV-positive mothers.

Year	New HIV Cases	AIDS Cases	CD4 Count at Diagnosis (Late Presenters)
2015	700+	200	<200 cells/mm³ (50%)
2020	450	150	<200 cells/mm³ (48%)
2025	331	86	<200 cells/mm³ (50%)

Contraindications & When to Consult a Doctor

While PrEP is highly effective, it is not suitable for everyone. Individuals with certain kidney problems should avoid PrEP. Regular monitoring of kidney function is essential for those taking PrEP. PrEP does not protect against other sexually transmitted infections (STIs), so consistent condom use is still recommended. If you experience any symptoms suggestive of HIV infection – such as fever, fatigue, swollen lymph nodes, or unexplained weight loss – consult a doctor immediately. Early diagnosis and treatment are crucial for managing HIV and preventing complications.

Hong Kong’s continued success in controlling the HIV epidemic depends on sustained commitment to prevention, testing, and treatment. The new community initiatives launched by the CHP are a positive step, but ongoing investment in research, education, and access to care is essential to ensure that the gains made in recent years are not lost. The global context, particularly the impact of funding cuts on HIV prevention programs, underscores the need for international collaboration and a renewed focus on addressing the HIV epidemic worldwide.

References

• National Institute of Allergy and Infectious Diseases (NIAID). (n.d.). HIV/AIDS.
• New England Journal of Medicine. (2014). Pre-exposure prophylaxis for HIV prevention among men who have sex with men.
• World Health Organization (WHO). (n.d.). HIV/AIDS.
• Centers for Disease Control and Prevention (CDC). (n.d.). What is HIV?.
• Chinadailyhk.com. (2025). New-HIV-infections-in-HK-decline-for-10th-consecutive-year.